2014
DOI: 10.1111/bph.12665
|View full text |Cite
|
Sign up to set email alerts
|

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7

Abstract: The endogenous ligands for the LT, lipoxin (LX) and oxoeicosanoid receptors are bioactive products produced by the action of the lipoxygenase family of enzymes. The LT receptors BLT1 and BLT2, are activated by LTB4 and the CysLT1 and CysLT2 receptors are activated by the cysteinyl‐LTs, whereas oxoeicosanoids exert their action through the OXE receptor. In contrast to these pro‐inflammatory mediators, LXA4 transduces responses associated with the resolution of inflammation through the receptor FPR2/ALX (ALX/FPR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
146
1
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 181 publications
(150 citation statements)
references
References 215 publications
(283 reference statements)
1
146
1
1
Order By: Relevance
“…Cysteinyl leukotrienes are proinflammatory agents that increase vascular permeability (26,29) through receptor-mediated activation of phospholipase C, phosphoinositide-3-kinase, and/or extracellular signal-related kinases (29,67,68). This increased permeability can increase extravasation of proangiogenic factors that can remodel the extracellular environment and promote growth of new vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Cysteinyl leukotrienes are proinflammatory agents that increase vascular permeability (26,29) through receptor-mediated activation of phospholipase C, phosphoinositide-3-kinase, and/or extracellular signal-related kinases (29,67,68). This increased permeability can increase extravasation of proangiogenic factors that can remodel the extracellular environment and promote growth of new vessels.…”
Section: Discussionmentioning
confidence: 99%
“…This raises interesting possibilities for what could activate ChemR23 and makes future experiments that study release of endogenous chemerin critical. Not only chemerin, but lipids such as resolvin E1, can activate ChemR23 (2).…”
Section: Does Chemerin Amplify Efs-induced Arterial Contraction?mentioning
confidence: 99%
“…Although FPRs have been named according to their capability to detect formylated peptides (5,17), these receptors can recognize structurally diverse agonists with no obvious common pattern in amino acid sequence or natural origin (3,16). Such ligands include N-formylated, C-amidated, and unmodified peptides from bacterial and viral pathogens as well as host-endogenous mitochondrial peptides and several nonpeptide agonists, such as resolvin D1 and lipoxin A4 (3,5,18). FPRs detect a wide range of structurally diverse pro-and antiinflammatory ligands associated with important human diseases, such as amyloidosis, Alzheimer disease, HIV, and inflammatory pain (19,20).…”
mentioning
confidence: 99%